World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
22216
World Ranking
18752
National Ranking
1698

Overview

Neil Barnes is affiliated with GlaxoSmithKline in the United Kingdom. Their primary research focus lies within the field of Medicine, with a significant concentration on Pulmonary and Respiratory Medicine.

Their work encompasses several subfields, including Physiology, Surgery, Behavioral Neuroscience, and Molecular Biology, with notable emphasis on respiratory-related conditions and treatments.

Key topics covered by Neil Barnes include:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Inhalation and Respiratory Drug Delivery
  • Respiratory and Cough-Related Research
  • Respiratory Support and Mechanisms
  • Eosinophilic Esophagitis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

They have contributed to several recent publications, including:

  • Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial, 2020, The Lancet Respiratory Medicine
  • Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis, 2021, European Respiratory Journal
  • Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression, 2020, British Journal of Clinical Pharmacology
  • High eosinophil counts predict decline in FEV1: results from the CanCOLD study, 2020, European Respiratory Journal
  • A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients, 2020, European Respiratory Journal

The scientist frequently publishes in the following venues:

  • European Respiratory Journal
  • International Journal of COPD
  • CHEST Journal
  • Respiratory Medicine
  • Journal of Allergy and Clinical Immunology

Frequent co-authors collaborating with Neil Barnes include:

  • Dave Singh
  • Paul Jones
  • David A. Lipson
  • Edward Kerwin
  • Zelie Bailes

Best Publications

  • British guideline on the management of asthma: A national clinical guideline

    Graham Douglas;Bernard Higgins;Neil Barnes;Anne Boyter

  • Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

    Patrick Flood-Page;Andrew Menzies-Gow;Simon Phipps;Sun Ying

  • Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.

    Terence C. O'shaughnessy;Tareq W. Ansari;Neil C. Barnes;Peter K. Jeffery

  • Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

    Steven Pascoe;Nicholas Locantore;Mark T Dransfield;Mark T Dransfield;Neil C Barnes;Neil C Barnes

  • A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

    Patrick Flood-Page;Cheri Swenson;Isidore Faiferman;John Matthews

  • Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society

    KF Chung;P Godard;E Adelroth;J Ayres

  • Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study

    Eric D Bateman;Gary T Ferguson;Neil Barnes;Nicola Gallagher

  • Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

    A.G. Alexander;A.B. Kay;N.C. Barnes

  • Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.

    N C Barnes;P J Piper;J F Costello

  • Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

    Ian D Pavord;Sally Lettis;Nicholas Locantore;Steve Pascoe

  • The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.

    Keith L. Hattotuwa;Mariusz J. Gizycki;Tareq W. Ansari;Peter K. Jeffery

  • Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

    C. J. Corrigan;P. H. Brown;N. C. Barnes;S. J. Szefler

  • Antiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease

    Neil C. Barnes;Yu-Sheng Qiu;Ian D. Pavord;Debbie Parker

  • Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial

    Adrian R Martineau;Wai Yee James;Richard L Hooper;Neil C Barnes

  • COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population

    Monica J Fletcher;Jane Upton;Judith Taylor-Fishwick;Sonia A Buist

  • A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma

    N. Barnes;I. Pavord;A. Chuchalin;J. Bell

  • Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

    Christopher H Compton;Jason Gubb;Richard Nieman;Jeffrey Edelson

  • Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

    K.P. Hui;N.C. Barnes

  • Antiinflammatory Effects of the Phosphodiesterase-4 Inhibitor Cilomilast (Ariflo) in Chronic Obstructive Pulmonary Disease

    Elizabeth Gamble;Diana C. Grootendorst;Christopher E. Brightling;Susannah Troy

  • Difficult/therapy-resistant asthma The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies ERS Task Force on Difficult/Therapy-Resistant Asthma

    P. Godard;E. Adelroth;J. Ayres;N. Barnes

Frequent Co-Authors

Ian D. Pavord
Ian D. Pavord University of Oxford
Nicolas Roche
Nicolas Roche Université Paris Cité
Steffen E. Petersen
Steffen E. Petersen Queen Mary University of London
Christopher Corrigan
Christopher Corrigan King's College London
David Price
David Price University of Aberdeen
Alberto Papi
Alberto Papi University of Ferrara
Mark T. Dransfield
Mark T. Dransfield University of Alabama at Birmingham
Amanda J. Lee
Amanda J. Lee University of Aberdeen
Paul W. Jones
Paul W. Jones St George's, University of London
Guy Brusselle
Guy Brusselle Ghent University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying medicine in the USA, there are several flexible online pathways that can launch or advance your healthcare career. For those interested in patient care or looking for a cost-effective start, online nursing programs offer accredited coursework and robust clinical experiences without the need to relocate or pause your career.

Nurses who wish to advance their qualifications can look into the cheapest dnp programs online, which provide a fast track to leadership or advanced clinical roles at an affordable rate. Registered nurses aiming for more senior positions will benefit from researching the cheapest rn to bsn program to upgrade their credentials with maximum flexibility and minimal financial burden.

If you hold a bachelor’s degree in another field and are considering a direct move into nursing, accelerated options like a direct entry msn online can help you quickly transition into advanced nursing practice. These pathways support varied career ambitions in healthcare, making it possible to advance on your own schedule and within your budget.

Best Scientists Citing Neil Barnes

Trending Scientists

Recently Published Articles